Real-world effectiveness of early molnupiravir or nirmatrelvir–ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study
Laboratory of Data Discovery for Health · University of Hong Kong · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
269
total citations
- FWCI
- 26.51
- Percentile
- 100%
- References
- 54
Citations per year
Authors
6- CKCarlos King Ho WongCorresponding
Laboratory of Data Discovery for Health, University of Hong Kong, Hong Kong Science and Technology Parks Corporation
- ICIvan Chi Ho Au
University of Hong Kong
- KTKristy T. K. Lau
University of Hong Kong
- EHEric H. Y. Lau
Laboratory of Data Discovery for Health, University of Hong Kong, Hong Kong Science and Technology Parks Corporation
- BJBenjamin J. CowlingCorresponding
Hong Kong Science and Technology Parks Corporation, Laboratory of Data Discovery for Health, University of Hong Kong
Topics & keywords
Topics
Keywords
- Coronavirus disease 2019 (COVID-19)
- Medicine
- Retrospective cohort study
- Cohort
- Ritonavir
- 2019-20 coronavirus outbreak
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Emergency medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.